Source: Menopause. Conference titles: Annual Meeting of Nams. Unidade: FSP
Subjects: CORONARIOPATIA, PREVALÊNCIA, FATORES DE RISCO
ABNT
FALUDI, A. A. et al. Does the presence of cardiovascular (CV) risk factors reduce the prevalence of hormone replacement therapy (HRT) use? [resumo]. Menopause. Washington: Faculdade de Saúde Pública, Universidade de São Paulo. . Acesso em: 14 nov. 2024. , 2000APA
Faludi, A. A., Aldrighi, J. M., Bertolami, M. C., & Paes, A. T. (2000). Does the presence of cardiovascular (CV) risk factors reduce the prevalence of hormone replacement therapy (HRT) use? [resumo]. Menopause. Washington: Faculdade de Saúde Pública, Universidade de São Paulo.NLM
Faludi AA, Aldrighi JM, Bertolami MC, Paes AT. Does the presence of cardiovascular (CV) risk factors reduce the prevalence of hormone replacement therapy (HRT) use? [resumo]. Menopause. 2000 ; 7( 6): 453.[citado 2024 nov. 14 ]Vancouver
Faludi AA, Aldrighi JM, Bertolami MC, Paes AT. Does the presence of cardiovascular (CV) risk factors reduce the prevalence of hormone replacement therapy (HRT) use? [resumo]. Menopause. 2000 ; 7( 6): 453.[citado 2024 nov. 14 ]